Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
16.33
+0.51 (3.26%)
Mar 4, 2026, 2:07 PM EST - Market open
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.68 billion as of March 4, 2026. Its market cap has increased by 25.78% in one year.
Market Cap
1.68B
Enterprise Value
1.09B
1-Year Change
25.78%
Ranking
Category
Stock Price
$16.33
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.68B, an increase of 138.45%. That is a compound annual growth rate of 16.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.63B | -15.45% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 1.70B |
| Oruka Therapeutics | 1.67B |
| Kodiak Sciences | 1.66B |
| Novavax | 1.65B |
| Harmony Biosciences Holdings | 1.65B |
| Immunocore Holdings | 1.64B |
| Sionna Therapeutics | 1.63B |
| Intellia Therapeutics | 1.63B |